- Home
- EFR vs AQST Comparison
EFR vs AQST Comparison
Compare EFR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- AQST
- Stock Information
- Founded
- EFR 2003
- AQST 2004
- Country
- EFR United States
- AQST United States
- Employees
- EFR N/A
- AQST N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- AQST Health Care
- Exchange
- EFR Nasdaq
- AQST Nasdaq
- Market Cap
- EFR 342.8M
- AQST 390.4M
- IPO Year
- EFR N/A
- AQST 2018
- Fundamental
- Price
- EFR N/A
- AQST $6.20
- Analyst Decision
- EFR
- AQST Strong Buy
- Analyst Count
- EFR 0
- AQST 7
- Target Price
- EFR N/A
- AQST $10.29
- AVG Volume (30 Days)
- EFR 88.6K
- AQST 3.7M
- Earning Date
- EFR 01-01-0001
- AQST 11-03-2025
- Dividend Yield
- EFR 9.43%
- AQST N/A
- EPS Growth
- EFR N/A
- AQST N/A
- EPS
- EFR 1.69
- AQST N/A
- Revenue
- EFR N/A
- AQST $44,132,000.00
- Revenue This Year
- EFR N/A
- AQST N/A
- Revenue Next Year
- EFR N/A
- AQST $51.50
- P/E Ratio
- EFR $7.74
- AQST N/A
- Revenue Growth
- EFR N/A
- AQST N/A
- 52 Week Low
- EFR $10.95
- AQST $2.12
- 52 Week High
- EFR $13.29
- AQST $6.43
- Technical
- Relative Strength Index (RSI)
- EFR N/A
- AQST 65.35
- Support Level
- EFR N/A
- AQST $5.47
- Resistance Level
- EFR N/A
- AQST $5.93
- Average True Range (ATR)
- EFR 0.00
- AQST 0.36
- MACD
- EFR 0.00
- AQST 0.02
- Stochastic Oscillator
- EFR 0.00
- AQST 72.96
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.